For the quarter ending 2026-03-31, PALX has $7,361,705 in assets. $351,970 in debts. $6,656,641 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 6,656,641 | |||
| Prepaids and other current assets | 168,860 | |||
| Total current assets | 6,825,501 | |||
| Property and equipment, gross | 318,336 | |||
| Less accumulated depreciation | 2,763 | |||
| Property and equipment, net | 315,573 | |||
| Right of use asset, net | 181,378 | |||
| Deferred financing costs | 30,000 | |||
| Other assets | 9,253 | |||
| Total assets | 7,361,705 | |||
| Accounts payable | 87,157 | |||
| Accrued expense and other liabilities | 82,884 | |||
| Operating lease liability, current | 58,821 | |||
| Total current liabilities | 228,862 | |||
| Operating lease liability, noncurrent | 123,108 | |||
| Total liabilities | 351,970 | |||
| Common stock, 0.0001 par value 300,000,000 shares authorized 18,920,686 and 18,770,686 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1,892 | |||
| Additional paid-in capital | 11,432,835 | |||
| Accumulated deficit | -4,424,992 | |||
| Total stockholders equity | 7,009,735 | |||
| Total liabilities and stockholders equity | 7,361,705 | |||
Palomino Laboratories Inc. (PALX)
Palomino Laboratories Inc. (PALX)